Fulgent Genetics, Inc.
FLGT
$18.50
$0.191.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 71.14M | 83.34M | 84.07M | 81.80M | 73.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.14M | 83.34M | 84.07M | 81.80M | 73.46M |
| Cost of Revenue | 49.65M | 50.75M | 48.56M | 47.37M | 45.12M |
| Gross Profit | 21.49M | 32.58M | 35.51M | 34.44M | 28.35M |
| SG&A Expenses | 37.31M | 50.70M | 34.98M | 38.68M | 33.76M |
| Depreciation & Amortization | 2.03M | 2.03M | 2.03M | 1.99M | 1.99M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 103.16M | 117.65M | 99.42M | 101.52M | 93.26M |
| Operating Income | -32.02M | -34.31M | -15.35M | -19.71M | -19.80M |
| Income Before Tax | -25.98M | -29.27M | -7.51M | -21.52M | -11.72M |
| Income Tax Expenses | -704.00K | -5.62M | -683.00K | -2.26M | 176.00K |
| Earnings from Continuing Operations | -25.27M | -23.65M | -6.83M | -19.26M | -11.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 448.00K | 232.00K | 218.00K | 299.00K | 369.00K |
| Net Income | -24.83M | -23.42M | -6.61M | -18.96M | -11.53M |
| EBIT | -32.02M | -34.31M | -15.35M | -19.71M | -19.80M |
| EBITDA | -26.02M | -28.20M | -9.31M | -13.66M | -13.88M |
| EPS Basic | -0.80 | -0.76 | -0.21 | -0.62 | -0.37 |
| Normalized Basic EPS | -0.46 | -0.54 | -0.15 | -0.23 | -0.23 |
| EPS Diluted | -0.80 | -0.76 | -0.21 | -0.62 | -0.37 |
| Normalized Diluted EPS | -0.46 | -0.54 | -0.15 | -0.23 | -0.23 |
| Average Basic Shares Outstanding | 30.88M | 30.98M | 30.75M | 30.54M | 30.83M |
| Average Diluted Shares Outstanding | 30.88M | 30.98M | 30.75M | 30.54M | 30.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |